Berberine, a plant-based compound, is being touted as a potential aid for weight loss, blood sugar control, and heart health, ...

The General Pharmaceutical Council (GPhC) has introduced new rules for weight-loss jabs, such as Wegovy and Mounjaro, in ...

If you take a GLP-1 medication, like Ozempic, Wegovy, Mounjaro, or Zepbound, you may want to take a look at your diet. These weight loss drugs are hailed for their ability to slow down digestion and ...

Schmidt warned that “even Ozempic’s not magic in itself ... you consent to our User Agreement and agree that your clicks, interactions, and personal information may be collected, recorded ...

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...

The FDA’s approval of Ozempic to battle chronic kidney disease “allows us to more broadly address conditions within cardiovascular-kidney-metabolic syndrome, which affects millions of ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Amy Schumer once hopped on board the Ozempic trend, but the side effects were so intense she had to stop. During a recent appearance on "The Howard Stern Show," the comedian, 43, opened up about ...

By Dana G. Smith and Dani Blum Over a decade ago, a smattering of studies suggested that early cousins of drugs like Ozempic and Mounjaro could prevent, or even reverse, signs of Alzheimer’s ...

Weight-loss drugs such as Ozempic have been a breakthrough because they eliminate the need to cut back or compensate by mimicking the gut hormone (GLP-1) and making people feel full faster.

“I looked great, but I couldn’t lift my head off the pillow,” the actress and comedian said Amy Schumer had a lot of success taking Ozempic for weight loss, quickly dropping 30 lbs ...

GLP-1 receptor agonist medications like Ozempic may do more than just change your waistline—they could influence how you shop at the grocery store. That’s the major takeaway from a new study ...